Amgen (AMGN) — insider trading
Health Care · NASDAQ
Amgen (AMGN) has 12 reported SEC Form 4 insider transactions in our data (latest 2026-05-19).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Austin Wanda M | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Drake Michael V | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Druker Brian | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | ECKERT ROBERT | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Garland Greg C. | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | HOLLEY CHARLES M | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | ISHRAK OMAR | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Jacks Tyler | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Klotman Mary E. | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Kullman Ellen Jamison | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-19 | MILES AMY E | Director | Grant / award / vesting | 665 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Busch Matthew C. | Officer (VP, Finance & CAO) | Shares withheld for taxes / exercise cost | 41 | $331.11 | $13.6K | Form 4 |
Ask the chat about AMGN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Amgen (AMGN).
Last updated 2026-05-19 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.